MX2018003640A - Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis. - Google Patents

Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis.

Info

Publication number
MX2018003640A
MX2018003640A MX2018003640A MX2018003640A MX2018003640A MX 2018003640 A MX2018003640 A MX 2018003640A MX 2018003640 A MX2018003640 A MX 2018003640A MX 2018003640 A MX2018003640 A MX 2018003640A MX 2018003640 A MX2018003640 A MX 2018003640A
Authority
MX
Mexico
Prior art keywords
ichthyosis
treatment
trifarotene
composition
foam containing
Prior art date
Application number
MX2018003640A
Other languages
English (en)
Inventor
Nadau-Fourcade Karine
Christophe BUGE Jean-
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of MX2018003640A publication Critical patent/MX2018003640A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Abstract

La presente invención se refiere a una composición autoespumante que contiene trifaroteno, destinada a la aplicación tópica sin enjuague, que comprende: - al menos una composición intermediaria B que comprende un agente generador de gas, - al menos una composición intermedia A que comprende un agente activador para el agente generador de gas, y - el trifaroteno o una de sus sales farmacéuticamente aceptables contenido en al menos una de las composiciones intermediarias A y B. La composición de acuerdo a la invención está destinada al tratamiento de la ictiosis. La presente invención se refiere igualmente a un kit o un recipiente único con varios compartimientos que contienen una composición de este tipo.
MX2018003640A 2015-09-29 2016-09-27 Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis. MX2018003640A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1559201A FR3041535B1 (fr) 2015-09-29 2015-09-29 Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
PCT/EP2016/073014 WO2017055297A1 (fr) 2015-09-29 2016-09-27 Mousse chimique non rincée contenant du trifarotène, et son utilisation dans le traitement de l'ichtyose

Publications (1)

Publication Number Publication Date
MX2018003640A true MX2018003640A (es) 2018-04-30

Family

ID=54848734

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018003640A MX2018003640A (es) 2015-09-29 2016-09-27 Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis.

Country Status (9)

Country Link
US (1) US11020348B2 (es)
EP (1) EP3355859A1 (es)
JP (1) JP2018529773A (es)
KR (1) KR20180057713A (es)
CN (1) CN108289838A (es)
AU (1) AU2016330790B2 (es)
FR (1) FR3041535B1 (es)
MX (1) MX2018003640A (es)
WO (1) WO2017055297A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6997222B2 (ja) 2017-06-23 2022-01-17 ザ プロクター アンド ギャンブル カンパニー 皮膚の外観を改善するための組成物及び方法
JP2021530447A (ja) 2018-07-03 2021-11-11 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 皮膚状態の治療方法
JP2023528616A (ja) 2020-06-01 2023-07-05 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649186B1 (en) 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
ATE400242T1 (de) 1997-11-07 2008-07-15 Medion Res Lab Inc Visköse zusammensetzungen mit kohlendioxid
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US5952372A (en) 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6177092B1 (en) 1998-11-10 2001-01-23 Color Access, Inc. Self-foaming cleansing systems
US6133310A (en) 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6399652B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
FR2830415B1 (fr) 2001-10-09 2004-07-09 Rhodia Chimie Sa Utilisation d'une composition a base de gomme xanthane en tant que stabilisant de mousses molles, et les mousses a base de cette composition
MXPA05004278A (es) * 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
US20050123487A1 (en) 2003-12-08 2005-06-09 Spadini Alessandro L. Stable nonaqueous liquid reactive skin care and cleansing packaged product
US20060057075A1 (en) 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US8916050B2 (en) 2004-09-27 2014-12-23 Special Water Patents B.V. Methods and compositions for treatment of water
US8158109B2 (en) 2006-03-31 2012-04-17 Stiefel Research Australia Pty Ltd Foamable suspension gel
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
FR2924944A1 (fr) 2007-12-18 2009-06-19 Galderma Sa Composition a base d'une avermectine et du soufre ou d'un derive du soufre, notamment pour le traitement de la rosacee
US10589134B2 (en) 2008-01-30 2020-03-17 Kimberly-Clark Worldwide, Inc. Hand health and hygiene system for hand health and infection control
DE102008029357A1 (de) 2008-06-20 2009-12-24 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Schäumende kosmetische Zubereitung
WO2010086726A1 (en) 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions for nail and skin treatment
FR2943914A1 (fr) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
AU2010249047A1 (en) 2009-05-13 2011-11-24 Protein Delivery Solutions, Llc Pharmaceutical system for trans-membrane delivery
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
US20110236503A1 (en) 2010-03-23 2011-09-29 Cosmalabs International, Llc Topical Skincare Composition
US8911713B2 (en) 2010-06-30 2014-12-16 Galderma Research & Development Method for preventing or treating skin tumor
US20130244976A1 (en) 2010-09-24 2013-09-19 Daido Chemical Corporation Foam-type external skin preparation
FR2969493B1 (fr) 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant du bpo
FR2969492B1 (fr) 2010-12-23 2013-07-05 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant de l'adapalene
FR2969491B1 (fr) 2010-12-23 2013-07-12 Galderma Res & Dev Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo
US9301935B2 (en) 2013-06-10 2016-04-05 Naeem Uddin Broad spectrum pharmacological composition for treatment of various infections and diseases and methods of use
EP3010487A4 (en) 2013-06-17 2016-12-07 Contract Pharmaceuticals Ltd NON-AEROSOL FOAM FOR TOPICAL ADMINISTRATION
US10857080B2 (en) * 2013-12-04 2020-12-08 Galderma Research & Development Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics
ES2704264T3 (es) 2014-03-28 2019-03-15 Galderma Res & Dev Espuma química que se aclara que contiene peróxido de benzoilo
BR112016022293A2 (pt) 2014-03-28 2017-08-15 Galderma Res & Dev Composição que contém peróxido de benzoíla, uso cosmético de uma composição, medicamento destinado a uma aplicação tópica sobre a pele, kit e processo de preparação de uma composição autoespumante
CN104382863B (zh) 2014-11-29 2017-07-07 河南后羿实业集团有限公司 一种禽用伊维菌素泡腾颗粒
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Also Published As

Publication number Publication date
US20180280298A1 (en) 2018-10-04
US11020348B2 (en) 2021-06-01
WO2017055297A1 (fr) 2017-04-06
FR3041535A1 (fr) 2017-03-31
CN108289838A (zh) 2018-07-17
EP3355859A1 (fr) 2018-08-08
AU2016330790B2 (en) 2022-05-12
FR3041535B1 (fr) 2019-01-25
KR20180057713A (ko) 2018-05-30
JP2018529773A (ja) 2018-10-11
AU2016330790A1 (en) 2018-05-10

Similar Documents

Publication Publication Date Title
MX2018003551A (es) Composicion limpiadora auto-espumante para enjuagar que contiene ivermectina.
MX2016012360A (es) Espuma quimica sin enjuague que comprende peroxido de benzoilo.
MX361338B (es) Espuma quimica que se remueve con enjuague que contiene peroxido de benzoilo.
MX2018003643A (es) Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento del acne.
CO2017004471A2 (es) Derivados de feniltriazol sustituido con hidroxialquilo y sus usos
PH12020550622A1 (en) Kras g12c inhibitors
DOP2018000240A (es) Derivados de piridiniltriazol sustituidos con amida y usos de estos
MX2018013983A (es) Inhibidores g12c de kras.
MX2020005484A (es) Formas solidas de un inhibidor de calicreina en plasma y sales del mismo.
MX2017004896A (es) Uso de hexadeca-8, 15-dienal como producto quimico aromatico.
MD20170016A2 (ro) Compuşi aminopirimidinici ca inhibitori JAK
MX2015011898A (es) Compuestos de pirazolo y usos de los mismos.
MX2018003640A (es) Espuma quimica sin enguaje que contiene trifaroteno y su uso en el tratamiento de la ictiosis.
UY37221A (es) Derivados de feniltriazol sustituidos con amida y usos de estos
UY35734A (es) Composiciones farmacéuticas que contienen refametinib
MX2018014176A (es) Capsulas que comprenden bencilpropargileteres para usar como inhibidores de la nitrificacion.
GEP201706741B (en) Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
MX2018003642A (es) Espuma quimica sin enjuage que contiene propionato de clobetasol y su uso en el tratamiento de la psoriasis.
PH12016501932A1 (en) Amido-substituted azole compounds
MX364187B (es) Composiciones antitranspirantes anhidras en aerosol.
MX2015007940A (es) Compuestos tricíclicos como inhibidores de cftr.
MX2018003647A (es) Espuma quimica sin enjuague que contiene brimonidina y su uso en el tratamiento de la rosacea.
IL285265A (en) Triamtrin or nolatrexad for use in the treatment of phenylketonuria
MX2016012366A (es) Espuma quimica sin enjuague que contiene adapaleno y peroxido de benzoilo.
MX2018003549A (es) Composicion limpiadora auto-espumante que contiene propionato de clobetasol y su uso en el tratamiento de la psoriaris.